Data / Form D filings / ELIXIRGEN THERAPEUTICS, INC.
ELIXIRGEN THERAPEUTICS, INC.: Form D filings
ELIXIRGEN THERAPEUTICS, INC., a biotechnology company in Baltimore, MD, filed 9 Form D notices with the SEC between 2018 and 2025. The latest, on November 13, 2025, reports $4 million sold of a $4 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 855 N. WOLFE ST., SUITE 624, Baltimore, MD, 21205
- Phone
- (443) 451-5300
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1744333
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | New notice | $4,000,000 | $4,000,000 | 1 | Oct 30, 2025 | sec.gov | |
| Apr 9, 2025 | New notice | $3,600,000 | $3,600,000 | 2 | Mar 31, 2025 | sec.gov | |
| Feb 12, 2025 | New notice | $600,000 | $600,000 | 2 | Jan 30, 2025 | sec.gov | |
| Dec 1, 2023 | New notice | $6,999,988 | $6,999,988 | 1 | Nov 9, 2023 | sec.gov | |
| Sep 29, 2022 | New notice | $5,000,000 | $5,000,000 | 1 | Sep 14, 2022 | sec.gov | |
| Feb 18, 2021 | New notice | $5,499,971 | $4,199,985 | $1,299,986 | 2 | Feb 2, 2021 | sec.gov |
| Aug 17, 2020 | Amendment | $5,706,889 | $5,706,889 | 3 | Nov 19, 2019 | sec.gov | |
| Dec 2, 2019 | New notice | $5,006,900 | $5,006,900 | 3 | Nov 19, 2019 | sec.gov | |
| Jun 25, 2018 | New notice | $3,999,998 | $3,999,998 | 1 | Jun 13, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| HIROAKI KOBAYASHI | Director | |
| THOMAS WHITE | Director | |
| JEFFREY CLELAND | Director | |
| MINORU KO | Director | |
| SHAUNA CALLAHAN | Director | |
| AKIHIRO KO | Executive Officer, Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Nov 10, 2025 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ELIXIRGEN THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.